Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7% growth in
HUM Earnings: Highlights of Humana’s Q4 2022 financial results
Categories
Medical Devices
BSX Infographic: Highlights of Boston Scientific’s Q4 2022 earnings report
Medical device maker Boston Scientific Corporation (NYSE: BSX) has announced financial results for the fourth quarter of 2022, reporting a decline in
Intuitive Surgical (ISRG) Earnings: 4Q22 Key Numbers
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported revenue of $1.66 billion for the fourth quarter of 2022, which was up 7% year-over-year. GAAP
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2022 earnings call dated Jan. 24, 2023 Corporate Participants: Jessica Moore -- Vice President of Investor Relations Joaquin
Boston Scientific Corp. (BSX) Q3 2022 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Abbott (ABT) Q3 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q3 2022 earnings call dated Oct. 19, 2022 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in double digits.
Intuitive Surgical, Inc. (ISRG) Q3 2022 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q3 2022 earnings call dated Oct. 18, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
JNJ Earnings: Johnson & Johnson Q3 adj. profit drops despite higher sales
Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase in net
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase in revenues.
Medtronic PLC (MDT) Q1 2023 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2023 earnings call dated Aug. 23, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
ABIOMED, Inc. (ABMD) Q1 2023 Earnings Call Transcript
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
Boston Scientific Corp (BSX) Q2 2022 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lauren Tengler -- Director of Investor Relations Michael F.
Intuitive Surgical Inc. (ISRG) Earnings: 2Q22 Key Numbers
Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $1.52 billion for the second quarter of 2022, up 4% year-over-year. GAAP net income
Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions Robert
ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment
ANGO Stock: Is it the right time to invest in AngioDynamics now?
The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But
Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for
OptMed all set for $24 million IPO. Here’s what you need to know
As IPO activity picks up momentum after a lull, technology and healthcare companies are dominating the scene as usual. The upcoming initial
Stock Watch: Key factors to consider before investing in Medtronic (MDT)
More than two years into the pandemic, the healthcare sector remains under stress due to continuing COVID care activities and hospitalizations. However,